Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eyesucom for protection of ocular epithelium in orthokeratology lens wearers
ChiCTR2000038279Phase 4Recruiting
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Feb 2019
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of eyesucom in corneal abrasion (2 arms), sponsored by Zhongshan Ophthalmic Center. Primary endpoint: Corneal fluorescein staining score. Started Feb 2019; status: recruiting.
02
Drugs
eyesucom
03
Conditions
corneal abrasion
Beyond the preview
Go deeper on ChiCTR2000038279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038279.